AzTrials
AzTrials

Borderline Personality DisorderNCT00131781

Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder

A study testing Cognitive Therapy and Supportive Therapy in people with Borderline Personality Disorder, run by Hospices Civils de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a randomised trial comparing cognitive therapy and supportive therapy administered along one year in borderline personality disorder. The follow-up is one year after treatments end. The therapists were the same in the two groups. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Borderline Personality Disorder
What is being tested?
Cognitive Therapy and Supportive Therapy
How many people
70 participants
Where
1 siteFrance
Study dates
Mar 2001to not given
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Adult, Older adult

Who may be able to join

  • DSM-4 DIBR >=8 (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Diagnostic inventory for borderline-revised)

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital Pierre Wertheimer

    Bron, 69677

Other trials in France

About this study

This is a randomised trial comparing cognitive therapy and supportive therapy administered along one year in borderline personality disorder. The follow-up is one year after treatments end.

The therapists were the same in the two groups. Patients received one session a week during six months and one session every two weeks during the next six months

Read the detailed description
  • Cognitive Therapy
  • Structured session
  • Conceptualization of the case with the patient
  • Cognitive methods
  • Guided discovery of the schemas
  • Work on life-scenarios
  • From scenarios to schemas
  • Empathic confrontation to the schemas
  • Building new schemas (Core belief work-sheet)
  • Affective methods: role playing
  • Interpersonal methods: counter transference issues
  • Behavioral experiment
  • Problem solving
  • Consolidation methods
  • Patients and therapists had manuals
  • Supportive Therapy
  • Therapist: active listening (face to face)
  • Empathy
  • Unconditional positive regard
  • Reformulation and clarification
  • Reflection of the patient's feelings
  • Reassurance
  • Therapist emphasizes the importance to ventilate problems
  • Therapist answers some factual questions
  • Therapist politely ignore or refuse requests for advice and directive attitudes
  • Therapist demonstrates warmth and genuineness
  • Patients and therapists had manuals
Being tested
Cognitive Therapy, Supportive Therapy
Keywords
Borderline personality disorder, Controlled trials, Cognitive Therapy, Supportive Therapy, suicide, impulsivity
Medical subject headings
Borderline Personality Disorder, Suicide, Impulsive Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive TherapyBehavioural

  • Supportive TherapyBehavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Global Impression (CGI): Improvement (1-7): score 3 ( a little better) associated with a hopelessness scale score < 8 (this means that the suicide risk is low)

Secondary outcomes (13)
  1. CGI severity and improvement

  2. Hamilton depression

  3. Beck Depression Inventory

  4. Hopelessness

  5. Young: Schema Questionnaire II

  6. Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Personality Disorders Personality Questionnaire (SCID II PQ)

  7. Minnesota Multiphasic Personality Inventory (MMPI) (minimult)

  8. Eysenck: impulsivity scale

  9. Checklist: impulsive risky behaviors

  10. Quality of life

  11. Handicap (Sheehan)

  12. Time: Pre test, six months, post test and one year post treatment follow-up

  13. Therapeutic relationship evaluation scale (patients and therapists)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2005 (estimated)
  2. Study startMar 2001

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Enrolment
70 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00131781
Sponsor's protocol ID
2000.230
Status last verified
Apr 2007
First submitted
18 Aug 2005
Last updated
27 Apr 2007
Results posted
No

Publications

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

    PubMed 32368793

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Therapy and Supportive Therapy in people with Borderline Personality Disorder, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Apr 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Global Impression (CGI): Improvement (1-7): score 3 ( a little better) associated with a hopelessness scale score < 8 (this means that the suicide risk is low). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00131781, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in